Early administration of pegfilgrastim contributes to the safety of DCF therapy as neoadjuvant chemotherapy for esophageal cancer

被引：0

作者：

Morita, Ryuichi ^{[1
]}

Ishikawa, Takeshi ^{[1
,2
]}

Endo, Yuki ^{[1
]}

Yasuda, Takeshi ^{[1
]}

Oka, Kaname ^{[1
]}

Sakakida, Tomoki ^{[1
]}

Matsumura, Shinya ^{[1
]}

Mizushima, Katsura ^{[1
]}

Doi, Toshifumi ^{[1
]}

Okayama, Tetsuya ^{[1
]}

Katada, Kazuhiro ^{[1
]}

Kamada, Kazuhiro ^{[1
]}

Uchiyama, Kazuhiko ^{[1
]}

Takagi, Tomohisa ^{[1
]}

Fujiwara, Hitoshi ^{[3
]}

Konishi, Hideyuki ^{[1
]}

Itoh, Yoshito ^{[1
]}

机构：

[1] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Mol Gastroenterol & Hepatol, Kyoto, Japan

[2] Kyoto Prefectural Univ Med, Univ Hosp, Outpatient Oncol Unit, Kyoto, Japan

[3] Grad Sch Med Sci, Div Digest Surg, Dept Surg, Kyoto, Japan

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.258

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MO40-5

引用

页码：S1422 / S1422

页数：1

共 50 条

[1] Efficacy and safety of early administration of pegfilgrastim for esophageal cancer treated with DCF: A phase 2 study
Yasuda, Tomoyo
Ishikawa, Takeshi
Dohi, Osamu
Okayama, Tetsuya
Yoshida, Naohisa
Kamada, Kazuhiro
Uchiyama, Kazuhiko
Handa, Osamu
Takagi, Tomohisa
Shiozaki, Atsushi
Fujiwara, Hitoshi
Konishi, Hideyuki
Naito, Yuji
Itoh, Yoshito
[J]. ANNALS OF ONCOLOGY, 2019, 30
[2] Safety and efficacy of prophylactic pegfilgrastim on day 3 of neoadjuvant DCF chemotherapy in elderly patients with resectable esophageal cancer.
Ikeda, Go
Yoshinami, Yuri
Kadono, Toru
Hirose, Toshiharu
Ohara, Akihiro
Itoyama, Mai
Azuma, Ikuko
Yamamoto, Shun
Honma, Yoshitaka
Ishiyama, Koshiro
Oguma, Jyunya
Daiko, Hiroyuki
Kato, Ken
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 375 - 375
[3] Docetaxel, cisplatin and fluorouracil as neoadjuvant chemotherapy for esophageal cancer with prophylactic pegfilgrastim
Maeda, Osamu
Koike, Masahiko
Fukaya, Masahide
Miyata, Kazushi
Iwata, Naoki
Nagino, Masato
Kodera, Yasuhiro
Ando, Yuichi
[J]. ANNALS OF ONCOLOGY, 2018, 29
[4] Predictive Factors of Febrile Neutropenia After Primary Prophylactic Pegfilgrastim With DCF Chemotherapy for Esophageal Cancer
Inagaki, Takahito
Sato, Miki
Kin, Masaoki
Otsuka, Koji
Murakami, Masahiko
Kogo, Mari
[J]. ANTICANCER RESEARCH, 2022, 42 (12) : 6071 - 6081
[5] A Case of Esophageal Cancer with Multiple Lymph Node Metastases which Responded to Neoadjuvant Chemotherapy (DCF therapy)
Shimakawa, Takeshi
Naritaka, Yoshihiko
Asaka, Shinichi
Isohata, Noriyuki
Yamaguchi, Kentaro
Murayama, Minoru
Konno, Soichi
Katsube, Takao
Ogawa, Kenji
Ide, Hiroko
[J]. ANTICANCER RESEARCH, 2010, 30 (01) : 221 - 226
[6] Docetaxel, cisplatin, and fluorouracil with pegfilgrastim on day 3 as neoadjuvant chemotherapy for esophageal cancer
Maeda, Osamu
Furune, Satoshi
Kanda, Mitsuro
Miyata, Kazushi
Shimizu, Dai
Sugita, Shizuki
Nishida, Kazuki
Ando, Masahiko
Kodera, Yasuhiro
Ando, Yuichi
[J]. CANCER MEDICINE, 2024, 13 (02):
[7] Efficacy of prophylactic pegfilgrastim on day three of preoperative DCF chemotherapy in elderly patients with resectable esophageal cancer
Ikeda, Go
Ohara, Akihiro
Itoyama, Mai
Azuma, Ikuko
Yamamoto, Shun
Honma, Yoshitaka
Oguma, Junya
Ishiyama, Koshiro
Daiko, Hiroyuki
Kato, Ken
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
[8] Multimodal Therapy of Esophageal Cancer Neoadjuvant Chemotherapy vs. neoadjuvant Chemoradiotherapy
Hoeppner, Jens
[J]. ONKOLOGE, 2016, 22 (07): : 509 - 510
[9] Neoadjuvant chemotherapy of esophageal cancer
Ribeiro, M.
Povoa, S.
Tavares, N.
Marques, C.
Fernandes, C.
Almeida, D.
Augusto, I.
[J]. ANNALS OF ONCOLOGY, 2016, 27 : 23 - 23
[10] Safety and feasibility of thoracoscopic esophagectomy after neoadjuvant chemotherapy for esophageal cancer
Yushi Fujiwara
Shigeru Lee
Satoru Kishida
Ryoya Hashiba
Ken Gyobu
Masashi Takemura
Harushi Osugi
[J]. Surgery Today, 2017, 47 : 1356 - 1360

← 1 2 3 4 5 →